unknown
Stage
1
Investors
About
Afynia offers a microRNA-based blood test to detect endometriosis. The company develops a molecular diagnostic intended to provide a non-invasive diagnostic option for this condition.
Explore Afynia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.